You are receiving this email because you have registered on OTPicks.com. To safely and permanently remove yourself from this list or manage your subscription please see the link below. OTPicks.com is not held liable or responsible for the information in press releases issued by the companies discussed in these emails. please always do your own due diligence. This is a paid Advertisement. By Opening and reading this email you certify that you have read our disclaimer in full and that you will perform your own research and due diligence, these emails should never be assumed to be 100% factual without independent research.
On-Time-Picks ^OTPicks.com ENRT Hello All And Welcome New Members, all eyes on ENRT right now Make sure you put ENRT on your radar right now and get ready for what could be a monster day! Enertopia Corp. (ENRT) recently released a four part video series in conjunction with its joint venture with The Green Canvas Ltd. After signing a joint venture agreement in February of 2014, the company has begun building and outfitting a 30,000 square foot facility – scalable to 55,000 square feet – to become compliant with Health Canada`s MMPR standards.
CLICK HERE TO SEE VIDEO The video tour of the planned facility includes everything from the initial clone rooms, perimeter security, vegetative grow areas, vaults, multiple staging areas for flowering, and the lights that will be used for production.
— ENRT — About ENRT The Enertopia Corporation is focused on the production, cultivation and distribution of Medical Marihuana (MMJ) under the new Canadian Federal Government Marihuana for Medical Purposes Regulations (MMPR) Program.
Enertopia currently owns an interest in 2 medical marihuana grow facilities in Canada.
—————– ENRT recently announced that it and joint venture partner Lexaria Corp have launched a formal Medical Advisory Board to educate and advocate on behalf of all those who have medical needs that may be able to be met through the understanding and use of medical marijuana or through the use of cannabidiol (CBD) extracted from Industrial Hemp.
The Medical Advisory Board members specialize in various medical categories, and will work with health care professionals, patients, and prescribers of medical marijuana to promote greater understanding of medical marijuana and of CBD-enhanced products. There are believed by many to be a wide variety of medical conditions that might be affected in a positive way either by medical marijuana or by CBD`s, but in many cases the accuracy of claims may not be well understood at this time.
In particular, the use of high-cannabidiol strains that have little or no psychoactive effects on the patient, are of interest for use to treat many medical symptoms, according to existing studies and literature.
Recreational use of Marijuana is illegal in Canada, and illegal at the federal level in the United States because of the THC content; and this status has prevented and or greatly reduced the opportunity for peer-reviewed scientific study. Still, there is growing evidence that there could be real medical benefits somehow associated with either medical marijuana and/or the CBD`s within it. Despite the hurdles to conducting past research, there are 1,277 references today to Cannabidiol at research papers located at the US National Library of Medicine, National Institutes of Health website (www.pubmed.gov).
Many organizations are calling for additional research regarding medical marijuana. For instance the Arthritis Society in September announced it wants more research to study the impact of medical marijuana on pain, and that it is preparing to fund clinical studies. Jason McDougall, chair of the Arthritis Society`s scientific advisory committee and a pain researcher at Dalhousie University was quoted at that time saying, “I think it`s high time that we found something to help the 4.6-million Canadians living with arthritis and trying to do something to help”.
Enertopia hopes to announce its first meetings and/or conferences as soon as possible in this sector and the wellness sector in general as the company moves forward.
Robert McAllister, Enertopia Corporation., President & CEO said, “We are all witnessing today the emergence of grass roots movement where the patient finally comes first in all aspects of wellness.” PUT ENRT ON YOUR RADAR RIGHT NOW! Make sure ENRT is on your radar right now! Happy Trading www.OTPicks.com is not a licensed financial advisor. This is a paid advertisement. PLEASE READ THIS DISCLAIMER IN FULL www. Otpicks.com does its best to bring you accurate information but errors may and sometimes do occur. Because these are paid advertisements we only focus on the positive aspects of each company or it’s stock. Please make sure you do your own research so you have all the facts. www.
Otpicks.com is not a licensed financial advisor. Investing in all OTC companies carries a high degree of risk due to their limited capital, operations, revenue and earnings. Readers need to assume that companies mentioned will never receive the funding necessary to fulfill its projections.
www. Otpicks.com , its owners, officers or principals or affiliates (as defined in the Securities Act of thirty three, as amended, and Rule 501(b) promulgated thereunder)and immediate family members, are hereafter collectively referred to as “ OTP ” or “we” or “us” or “our”). OTP publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. OTP does not undertake any due diligence or investigation of the Information it obtains or publishes. You should not consider the Information published by OTP to be a true, accurate, complete or reliable. The Profiled Companies actual results and financial condition may differ materially and be completely different than that published or described in the Information. The Information is not an offer or solicitation to buy or sell securities of the Profiled Companies. You should not consider the Information to be a recommendation or indication as to when you should buy or sell securities or if you should buy or sell securities of the Profiled Companies.
In order to be in full compliance with the Securities Act of 1933, Section 17(b), OTP is owned and operated by OTP . Neither OTP nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since OTP receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in OTP statements and opinions and such statements and opinions cannot be considered independent. OTP and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements.
OTP and its officers, directors, owners and employees are not licensed as brokers, broker dealers, market makers, investment bankers, investment advisors, analysts or underwriters. You should not consider the Information when making an investment decision of whether to buy or sell securities of any Profiled Company on OTP and you should consult with and request that your investment advisor or attorney verify any information you rely upon in making an investment decision. You should consult your financial and legal advisers before purchasing or selling the securities of any Profiled Company. Affiliates, officers, directors and employees of OTP may own or may purchase shares of the Profiled Companies and may sell their securities at times when OTP publishes Information on the Profiled Company including when investors purchase the securities of the Profiled Companies. OTP uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. The use of our information should be based on your own due diligence, and you agree that our company is not liable for any success or failure of your business that is directly or indirectly related to the use of our information. As with any business, your results may vary, and will be based on your individual capacity, business experience and expertise. There are no guarantees concerning the level of success you may experience.
The owners, associates, officers, directors and/or employees and/or principals of OTP may have stock positions in the Profiled Companies obtained from purchases in the open market or in private transactions. OTP will liquidate any securities of the Profiled Companies at its discretion without notification to any party including you even it has made published positive Information about a Profiled Company. This should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. However we will disclose any stock/short positions of the currently profiled company that Otpicks.com owners/directors hold (regardless of size)within our alert emails. Any questions/concerns may be asked by simply replying to this email . The Information is not a solicitation or recommendation to buy, sell or hold securities and does not provide reliable information or analysis of the financial position of the Profiled Companies. All statements in the Information are subject to change without notice and are not reliable. OTP is not liable for any investment decisions by its readers. Readers should independently investigate and fully understand all risks before investing in any Profiled Company.
Any investment in the Profiled Companies involves a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results.
The information contained herein contains “forward-looking statements,” within the meaning of S.ection 27A of the Securities Act of 1933 and S.ection 21E of the Securities E.xchange Act of 1934. Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated.
Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in public information including but not limited to reports filed with the Securities and Exchange Commission and/or OTC Markets. obtain information about some of the Profiled Companies from the OTC Markets Website atwww.otcmarkets. com or from the website of the Securities and Exchange Commission, at http://www.sec. gov without charge.
Buying and Selling of Shares The securities of the Profiled Companies are high risk, unstable, unpredictable and illiquid. The securities of the Profiled Companies are considered in most circumstances to be penny stocks and should not be purchased by anyone who cannot sustain a complete loss of their investment.
If you cannot sustain the loss of your entire investment you should not purchase securities of the Profiled Companies. If at any time you wish to be removed from our list simply